
Glaxy Medipharma Private Limited
About Glaxy Medipharma Private Limited
Data last updated:
Glaxy Medipharma Private Limited was a private limited company based in Lucknow, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the data processing and IT services segment of the technology and IT services sector. It was incorporated on 23 February 2011.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U72300UP2011PTC043703.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors Aruna Singh and Suresh Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at E – 131 Kurmanchal Nagar Indira Nagar, Lucknow, Uttar Pradesh, India – 226016.
Company details
Contact details
Glaxy Medipharma Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressE – 131 Kurmanchal Nagar Indira Nagar, Lucknow, Uttar Pradesh, India – 226016
- IndustryInformation Technology, Data Processing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glaxy Medipharma Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Glaxy Medipharma Private Limited, buy the company report.
Board of directors of Glaxy Medipharma Private Limited
Glaxy Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aruna Singh Also directs: Prime Shift Logistics Private Limited | Director | 23 Feb 2011 | 15 Years 8 Months | As last reported |
| Suresh Pratap Singh Also directs: Prime Shift Logistics Private Limited | Director | 23 Feb 2011 | 15 Years 8 Months | As last reported |
Legal cases
No court or tribunal cases involving Glaxy Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glaxy Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glaxy Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glaxy Medipharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Aruna Singh was appointed as Director on 23 Feb 2011.
Frequently asked questions
Glaxy Medipharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Glaxy Medipharma was a private limited company based in Lucknow, Uttar Pradesh, India. The company worked in data processing, within the information technology industry. It was incorporated on 23 February 2011 and is registered under CIN U72300UP2011PTC043703. The company has been struck off by the Registrar of Companies and is no longer operational.
Glaxy Medipharma had 2 directors:
- Aruna Singh - Director
- Suresh Pratap Singh - Director
The CIN (Corporate Identification Number) of Glaxy Medipharma is U72300UP2011PTC043703. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Glaxy Medipharma is at E – 131 Kurmanchal Nagar Indira Nagar, Lucknow, Uttar Pradesh, India – 226016.
Glaxy Medipharma was incorporated on 23 February 2011. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Glaxy Medipharma on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Glaxy Medipharma operated in the information technology industry, in the data processing segment. It worked in this industry before it was struck off.
Aruna Singh was appointed as Director on 23 Feb 2011. Suresh Pratap Singh was appointed as Director on 23 Feb 2011.
The compliance status of Glaxy Medipharma is active non-compliant as of 15 August 2026.

